48,837
edits
Line 1,261: | Line 1,261: | ||
*SMARCB1 (INI1) -ve.<ref name=Ref_WMSP286>{{Ref WMSP|286}}</ref> | *SMARCB1 (INI1) -ve.<ref name=Ref_WMSP286>{{Ref WMSP|286}}</ref> | ||
==Acquired cystic disease renal cell carcinoma== | ==Acquired cystic disease-associated renal cell carcinoma== | ||
*[[AKA]] '' | *[[AKA]] ''ACD-RCC''. | ||
===General=== | ===General=== | ||
* | *Arise in the context of long-standing end-stage renal disease (ESRD).<ref name=pmid23471757>{{Cite journal | last1 = Ahn | first1 = S. | last2 = Kwon | first2 = GY. | last3 = Cho | first3 = YM. | last4 = Jun | first4 = SY. | last5 = Choi | first5 = C. | last6 = Kim | first6 = HJ. | last7 = Park | first7 = YW. | last8 = Park | first8 = WS. | last9 = Shim | first9 = JW. | title = Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features. | journal = Med Mol Morphol | volume = | issue = | pages = | month = Mar | year = 2013 | doi = 10.1007/s00795-013-0028-x | PMID = 23471757 }}</ref> | ||
===Microscopic=== | ===Microscopic=== |
edits